Try our mobile app
Ascendis Health Limited (JSE:ASC) News - Additional Shareholder Demand
Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis Health” or “the Company”)
ADDITIONAL SHAREHOLDER DEMAND
Shareholders are referred to the announcement published on SENS on 31 March 2022 (“31 March
Announcement”) in which they were advised that the Company had received an Additional Demand in terms of
section 61(3) of the Companies Act, read with clause 20.1.3 of the Company’s Memorandum of Incorporation
from a different group of shareholders who together hold Ascendis Health shares representing more than 10% of
the Company’s voting rights, to include resolutions to appoint Maki Modisakeng, Samuel Miller and Francois
Theron as independent non-executive directors of the Company in terms of article 26 of the Company’s
Memorandum of Incorporation. The capitalised terms used in this announcement bear the same meaning as
those defined in the 31 March Announcements.
Resolutions in respect of the Additional Demand were included in the Notice of Special General Meeting that was
distributed to shareholders on 31 March 2022.
Shareholders are hereby advised that the Additional Demand was received from Kefolile Health Investments
Proprietary Limited, and Nicolaas van der Westhuizen, who together hold Ascendis Health shares representing
more than 10% of the Company’s voting rights.
6 April 2022
Bryanston
Sponsor
Questco Corporate Advisory Proprietary Limited
Date: 06-04-2022 05:10:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
